Treatment of massive cecal bleeding in a 28-year-old patient with homozygous factor V deficiency with activated factor VII

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 3, 2008, Pages 271-273

  Petros, S ^a   Fischer, J ^a   Mossner J ^a   Schiefke, I ^a   Teich, Niels ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Cecal bleeding; Factor V deficiency; Haematochezia; Recombinant activated factor VII

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE REPORT; CECUM DISEASE; COLON MUCOSA; COLONOSCOPY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; LARGE INTESTINE HEMORRHAGE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOELASTOGRAPHY; UPPER GASTROINTESTINAL TRACT;

ADULT; CECAL DISEASES; COAGULANTS; FACTOR VII DEFICIENCY; FACTOR VIIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; TREATMENT OUTCOME;

EID: 41949127018     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963377     Document Type: Article

References (10)

1. Sørensen B, Johansen P, Christiansen K et al. Whole blood coagulation thromboelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-558
2. Peyvandi F, Duga S, Akhavan S et al. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-321
3. Girolami A, Scarano L, Girolami B et al. Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification. Blood Rev 1998; 12: 45-51
4. Lak M, Sharifian R, Peyvandi F et al. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Thromb Haemost 1998; 83: 1067-1071
5. Ajzner E, Balogh I, Haramura G et al. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding. J Thromb Haemost 2003; 1: 943-949
6. Mann KG. How much factor V is enough? Thromb Haemost 2000; 83: 3-4
7. Hoffman M, Monroe 3 rd DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9: S61-65
8. Altistent C, Lozano M, Sol E et al. Dental extraction using rFVIIa in a patient with severe factor V deficiency. Haemophilia 2000; 6: 408-412
9. Divanon F, Hecquard C, Borel-Derlon A. Experience with use of recombinant activated factor VII. J Clin Pharm Ther 2002; 27: 133-138
10. Gonzalez-Boulloso R, Ocampo-Martinez R, Alarcon-Martin MJ et al. The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency. Haemophilia 2005; 11: 167-170